Skip to main content
DNTH logo

DNTH · Dianthus Therapeutics, Inc. /DE/

Track DNTH — free
$115.96 +6.36 (+5.80%) At close · Aug 14
Market Cap
$6.49B
Shares
55.93M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-08-10 ANNE M MCGEORGE 7,750
2026-08-10 ADAM VENESS 16,167
2026-08-10 Read Simon 5,550
2026-08-07 MARINO GARCIA 126,000
2026-08-07 ADAM VENESS 3,833
2026-08-07 MARINO GARCIA 40,000
2026-07-09 RYAN SAVITZ 31,249
2026-06-17 ADAM M VENESS 30,000
2026-06-01 SIMRAT RANDHAWA 26,530
2026-04-09 RYAN SAVITZ 8,224
2026-03-31 PAULA C SOTEROPOULOS 1,198
2026-03-31 RYAN SAVITZ 114,367
2026-03-24 PAULA C SOTEROPOULOS 27,594
2026-03-12 MARINO GARCIA 122,918
2026-03-12 EDWARD CARR 43,682
2026-03-12 SIMRAT RANDHAWA 33,830
2025-12-04 RYAN SAVITZ 20,000
2025-11-13 SIMRAT RANDHAWA 196,538
2025-09-09 RYAN SAVITZ 20,000
Showing 1–19 of 19 filings
Key facts CIK 1690585 CUSIP 252828108 13F (30d) 263 filings 259 filers Visit website Investor relations